Nice analysis. In addition to your post, we are yet to hear whether the Dosecann sale was finalised by CBW, and if it’s a fait accompli, then what is management planning to do with either the funds or CBW shares? Hmm, another quick turnaround? Furthermore, the Weed Me investment in tandem with Fire & Flower, both investments seemingly on the cusp of generating some near term revenue perhaps?
My guess is that a few holders and non-holders haven’t researched the portfolio in its entirelty (unlike yourself), and made linear judgements therein, but I’m exceedingly happy to wait for the market to discern the $hit from clay with MMJ. I might add that while the ESE investment may turn out to be an epic fail, it may assist with H1’s growth of products from Dream Water. Time will tell, but I’m starting to get a little more excited as the second half of 2018 draws nearer.
Add to My Watchlist
What is My Watchlist?
